Biokine Announces Issuance of European Patent

Biokine Therapeutics Announces Issuance of European Patent covering the composition and use of novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation, and cancer (BKT130 project).

Biokine Announces Issuance of European Patent2015-01-25T09:57:21+02:00

Biokine Announces Issuance of Mexican Patent

Biokine Therapeutics Announces Issuance of Mexican Patent covering the composition and use of novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation, and cancer (BKT130 project).

Biokine Announces Issuance of Mexican Patent2015-01-25T09:55:34+02:00

Biokine Therapeutics Announces Issuance of United States Patent covering the composition and use of peptides for inhibiting chemokine binding to chemokine receptors

Biokine Therapeutics Announces Issuance of United States Patent covering the composition and use of peptides for inhibiting chemokine binding to chemokine receptors (BKT130 Project).

Biokine Therapeutics Announces Issuance of United States Patent covering the composition and use of peptides for inhibiting chemokine binding to chemokine receptors2014-11-30T21:04:18+02:00

Biokine Therapeutics Announces Issuance of Japanese Patent covering the composition and use of polypeptides

Biokine Therapeutics Announces Issuance of Japanese Patent covering the composition and use of polypeptides

Biokine Therapeutics Announces Issuance of Japanese Patent covering the composition and use of polypeptides2014-11-30T21:02:15+02:00

Biokine Therapeutics Announces Issuance of Chinese Patent covering the composition and use of novel chemokine binding polypeptides

Biokine Therapeutics Announces Issuance of Chinese Patent covering the composition and use of novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation, and cancer (BKT130 project). Read More

Biokine Therapeutics Announces Issuance of Chinese Patent covering the composition and use of novel chemokine binding polypeptides2021-04-20T15:49:36+02:00

Biokine Therapeutics Announces Issuance of United States Patent covering the use of CXCR4 antagonist for wound healing

Biokine Therapeutics Announces Issuance of United States Patent covering the use of CXCR4 antagonist for wound healing and re-epithelialization (BKT170 Project). Read More

Biokine Therapeutics Announces Issuance of United States Patent covering the use of CXCR4 antagonist for wound healing2021-04-20T15:49:36+02:00

Biokine Therapeutics Announces Issuance of United States Patent

Biokine Therapeutics Announces Issuance of United States Patent covering the composition and use of novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation, and cancer (BKT130 project).

Biokine Therapeutics Announces Issuance of United States Patent2014-11-30T20:54:24+02:00
Go to Top